You just read:

Synthetic Biologics Announces Positive Topline Results from Second Phase 2a Clinical Trial of SYN-004 for the Prevention of C. difficile Infection and Antibiotic-Associated Diarrhea

News provided by

Synthetic Biologics, Inc.

May 16, 2016, 06:58 ET